nph, big news a comingwaiting anyday, regarding NOC...VANC will start manufacturing of these products once Notice of Compliance (NOC) is received from Health Canada, which is anticipated in the next few weeks. The NOC from Health Canada provides the authorization for VANC to market and sell the generic molecules in Canada. "We are excited to continue growing our portfolio of generic drugs as we work towards commercialization this quarter," said Arun Nayyar, CEO of VANC. "We will continue to expand our portfolio with niche market molecules that are applicable to the Canadian market."
from May 4 news release